missing translation for 'onlineSavingsMsg'
Learn More
Learn More
PF 04620110
Potent and selective DGAT-1 inhibitor; orally bioavailable
£95.05 - £360.00
Specifications
| Chemical Name or Material | trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexaneacetic acid |
|---|---|
| CAS | 1109276-89-2 |
| Assay Percent Range | >98% |
| Molecular Formula | C21H24N4O4 |
| Formula Weight | Observed MW: 396.44 |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
18781388
|
Tocris Bioscience
5863/25 |
25 mg |
£360.00
25mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
18778228
|
Tocris Bioscience
5863/5 |
5 mg |
£95.05
5mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
Potent and selective DGAT-1 inhibitor (IC50 = 19 nM). Exhibits >1000-fold selectivity for DGAT-1 over DGAT-2, and no significant activity against a range of other enzymes, ion channels and receptors. Reduces plasma triglyceride levels in a rat lipid challenge model. Orally bioavailable.Specifications
| trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexaneacetic acid | |
| >98% | |
| Observed MW: 396.44 |
| 1109276-89-2 | |
| C21H24N4O4 |
Safety and Handling
Recommended Storage : Store at 4°C
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title